VisiRose, a collaboration between Provectus Biopharmaceuticals and Bascom Palmer Eye Institute, is introducing a therapy for the treatment of infectious keratitis and other eye infections, according to a press release.
Rose bengal photodynamic antimicrobial therapy (RB PDAT), a noninvasive investigational treatment, uses a formulation of synthetic small molecule rose bengal sodium from Provectus and a light-based medical device from Bascom Palmer to treat eye infections, according to the release. VisiRose said the therapy may address antimicrobial resistance by providing a broad-spectrum